As of Jun 24
| -0.11 / -1.55%|
The 1 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +57.14% increase from the last price of 7.00.
The current consensus among 1 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.